TMZ benefit is essentially low hanging fruit for DCVax to benefit from. Your concern about its use confounding the data is basically a non issue since no clinical trial was done to prove that potential benefit was as a result of its continued use. Your quote explains the undefined reasons why. DCVax protocol indicates that all benefit from additional therapies will be credited to DCVax with regard to OS outcome. So come on RK, it's OK to smile once in a while here.
News 
Market Data 
Discover 
